Advertisement
CTVA vs FMC
Which Stock Would AI Choose? Corteva (CTVA) vs. FMC Corporation (FMC) Stock Comparison
Key Takeaways
- Corteva (CTVA) has completed the spin-off of its seed and genetics business (now Vylor), transforming into a pure-play crop protection company focused on agricultural chemicals.
- FMC Corporation (FMC) is navigating a difficult post-patent transition, weak crop prices, and an elevated debt load, with management guiding for a full-year 2026 earnings decline.
- The two firms are directly linked: FMC recently received a $200 million upfront licensing payment from Corteva for its rimisoxafen molecule, a notable intersection of their portfolios.
- Corteva is drawing fresh analyst upgrades following the spin-off, while FMC is executing asset sales and a balance-sheet repair plan.
- Their risk profiles diverge sharply: Corteva faces environmental (PFAS-related) liabilities, while FMC faces leverage, pricing pressure, and product-concentration risks.
Introduction
Both CTVA and FMC operate in agricultural chemicals, yet they sit at very different points in the market cycle and their corporate lifecycles. This stock comparison is relevant for investors and traders seeking exposure to crop protection, an industry sensitive to commodity prices, farmer spending, and regulatory shifts. Corteva has just reorganized around its chemicals franchise, while FMC is working through a multi-year turnaround. Understanding how these two names differ in market positioning, financial health, and relative performance can help readers weigh growth potential against balance-sheet and legal risks.
CTVA Overview and Recent Performance
CTVA is Corteva, Inc., a crop protection leader that recently completed the spin-off of its advanced seed and genetics business, now trading separately as Vylor. The transaction left Corteva as a focused agricultural chemicals company with roughly $9 billion in estimated market value for the remaining business. Because most of the company's value moved to the new entity, the share price reset substantially lower on the spin-off date—a mechanical adjustment rather than a fundamental loss.
In recent weeks, sentiment has improved as several analysts recalibrated coverage. JPMorgan upgraded the stock to Overweight with a $19 price target, describing the crop chemicals business as undervalued, while Oppenheimer and KeyBanc also reiterated constructive views. Supporting the thesis, Corteva's crop protection segment grew sales by more than $1 billion from 2020 through 2025 and expanded its operating EBITDA (earnings before interest, taxes, depreciation, and amortization) margin by roughly 250 basis points. The company also cites an approximately $11 billion product pipeline and says about 65% of sales come from differentiated crop technology. The principal overhang is inherited legal exposure to PFAS and PFOA substances—often called "forever chemicals"—tied to its historical DuPont lineage.
FMC Overview and Recent Performance
FMC is FMC Corporation, an agricultural sciences company developing and selling insecticides, herbicides, and fungicides. The stock has faced a multi-year decline, falling roughly 90% from its early-2022 peak, as key molecules came off patent, crop prices weakened, and channel inventories were reset. In its most recent reported quarter, revenue declined about 17% year over year and the company posted a net loss, while full-year 2026 guidance points to lower revenue, adjusted EBITDA, and adjusted EPS versus the prior year.
Management has framed the period as an earnings trough, with CEO Pierre Brondeau stating that "the worst is behind us" and forecasting 2027 as a return to growth. To strengthen the balance sheet, FMC has pursued roughly $1 billion in debt-reduction initiatives, including the sale of its India commercial business for $252 million, a $400 million minority equity investment from Tessenderlo Group, and the $200 million rimisoxafen licensing payment from Corteva. Regulatory wins such as European Union approval for its Isoflex active ingredient—the first new herbicide approved in the EU since 2019—offer a longer-term catalyst, but near-term leverage and pricing pressure remain central concerns.
Trending AI Robots
For traders evaluating names like CTVA and FMC, Tickeron's Trending AI Robots page offers a curated view of automated strategies. Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, each with its own trading style, timeframe, performance history, statistics, and watchlist. Rather than listing every available bot, the Trending section highlights only those best suited to current market conditions. This selection approach can help traders and investors identify systematically generated signals without manually screening the broader bot library. Explore the Trending AI Robots to see which automated strategies are gaining traction in the present environment.
Head-to-Head Comparison
The two companies share a sector but not a growth profile. Corteva is a recently simplified pure-play with a strong product pipeline and an improving analyst stance, while FMC is a deleveraging turnaround that is still guiding for meaningful earnings contraction. On financial health, Corteva holds a comparatively cleaner balance sheet, whereas FMC carries elevated debt that it is actively paying down through divestitures and licensing deals.
Their growth drivers also differ. Corteva's case rests on crop protection pricing, new molecules, and a re-rating following the spin-off, while FMC's case leans on new active ingredients—growing more than 75% at the midpoint of guidance—and a post-patent strategy for its Rynaxypyr franchise. Risk factors cut in opposite directions: Corteva's main uncertainty is environmental litigation, while FMC's is product concentration, generic competition, and balance-sheet flexibility. Market sentiment has recently favored Corteva following analyst upgrades, whereas FMC's sentiment hinges on execution of its restructuring and debt-reduction milestones.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely favor CTVA at present. The stock demonstrates a more stable fundamental footing—positive segment-level growth, a large pipeline, and a post-spin re-rating supported by multiple analyst upgrades—alongside a cleaner balance sheet. FMC's turnaround thesis is plausible but remains more dependent on execution, with persistent pricing pressure, elevated leverage, and near-term earnings declines weighing on trend consistency. Accordingly, an AI-driven assessment would probably assign higher probability to Corteva for relative strength and stability, while treating FMC as a higher-risk, catalyst-dependent opportunity rather than a current leader.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTVA is a Hold and FMC is a Buy.
CTVA in upward trend: price may jump up because it broke its lower Bollinger Band on October 27, 2026
CTVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 39 cases where CTVA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CTVA's RSI Oscillator exited the oversold zone, 22 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 53 cases where CTVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CTVA as a result. In 48 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for CTVA just turned positive on November 10, 2026. Looking at past instances where CTVA's MACD turned positive, the stock continued to rise in 30 of 46 cases over the following month. The odds of a continued upward trend are 65%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTVA advanced for three days, in 216 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
CTVA moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTVA crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The Aroon Indicator for CTVA entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.316) is normal, around the industry mean (-0.492). P/E Ratio (7.778) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.011) is also within normal values, averaging (0.867). Dividend Yield (0.026) settles around the average of (0.126) among similar stocks. CTVA's P/S Ratio (3.069) is slightly higher than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. CTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
FMC's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for FMC turned positive on October 30, 2026. Looking at past instances where FMC's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FMC's RSI Oscillator exited the oversold zone, 21 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on FMC as a result. In 60 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMC advanced for three days, in 173 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
FMC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 53 cases where FMC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for FMC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (-0.492). P/E Ratio (-0.256) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.532) is also within normal values, averaging (0.867). Dividend Yield (0.057) settles around the average of (0.126) among similar stocks. P/S Ratio (0.416) is also within normal values, averaging (1.476).
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. FMC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
CTVA | FMC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 24 | 100 | |
SMR RATING 1..100 | 85 | 98 | |
PRICE GROWTH RATING 1..100 | 51 | 66 | |
P/E GROWTH RATING 1..100 | 96 | 10 | |
SEASONALITY SCORE 1..100 | 55 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CTVA's Valuation (50) in the null industry is in the same range as FMC (50) in the Chemicals Agricultural industry. This means that CTVA’s stock grew similarly to FMC’s over the last 12 months.
CTVA's Profit vs Risk Rating (24) in the null industry is significantly better than the same rating for FMC (100) in the Chemicals Agricultural industry. This means that CTVA’s stock grew significantly faster than FMC’s over the last 12 months.
CTVA's SMR Rating (85) in the null industry is in the same range as FMC (98) in the Chemicals Agricultural industry. This means that CTVA’s stock grew similarly to FMC’s over the last 12 months.
CTVA's Price Growth Rating (51) in the null industry is in the same range as FMC (66) in the Chemicals Agricultural industry. This means that CTVA’s stock grew similarly to FMC’s over the last 12 months.
FMC's P/E Growth Rating (10) in the Chemicals Agricultural industry is significantly better than the same rating for CTVA (96) in the null industry. This means that FMC’s stock grew significantly faster than CTVA’s over the last 12 months.
| CTVA | FMC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 56% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 75% |
| Advances ODDS (%) | 3 days ago 63% | 2 days ago 60% |
| Declines ODDS (%) | 7 days ago 55% | 4 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 50% |
| Aroon ODDS (%) | 2 days ago 48% | 2 days ago 72% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CTVA’s FA Score shows that 1 FA rating(s) are green while FMC’s FA Score has 1 green FA rating(s).
- CTVA’s FA Score: 1 green, 4 red.
- FMC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CTVA’s TA Score shows that 6 TA indicator(s) are bullish while FMC’s TA Score has 5 bullish TA indicator(s).
- CTVA’s TA Score: 6 bullish, 4 bearish.
- FMC’s TA Score: 5 bullish, 3 bearish.
Price Growth
CTVA (@Chemicals: Agricultural) experienced а -0.98% price change this week, while FMC (@Chemicals: Agricultural) price change was -11.99% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Agricultural industry was -3.54%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -20.52%.
Reported Earning Dates
CTVA is expected to report earnings on Feb 03, 2027.
FMC is expected to report earnings on Feb 09, 2027.
Industries' Descriptions
@Chemicals: Agricultural (-3.54% weekly)The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.
Advertisement
FMC and
Correlation & Price change
A.I.dvisor indicates that over the last year, FMC has been loosely correlated with CTVA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FMC jumps, then CTVA could also see price increases.
| Ticker / NAME | Correlation To FMC | 1D Price Change % | ||
|---|---|---|---|---|
| FMC | 100% | +0.18% | ||
| CTVA - FMC | 41% Loosely correlated | -0.25% | ||
| MOS - FMC | 32% Poorly correlated | -0.83% | ||
| NTR - FMC | 30% Poorly correlated | -0.72% | ||
| IPI - FMC | 22% Poorly correlated | -1.29% | ||
| BIOX - FMC | 20% Poorly correlated | +9.20% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NUDV | 34.76 | 0.20 | +0.59% |
| Nuveen ESG Dividend ETF (NUDV) | |||
| VFH | 141.89 | 0.65 | +0.46% |
| Vanguard Financials ETF (VFH) | |||
| LOCT | 23.82 | 0.04 | +0.17% |
| Innovator Premium Income 15 Buffer ETF - October (LOCT) | |||
| COM | 33.60 | 0.04 | +0.10% |
| Direxion Auspice Broad Commodity Strategy ETF (COM) | |||
| BIT | 11.29 | -0.06 | -0.53% |
| BLACKROCK MULTI-SECTOR Income TRUST | |||